These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 19041069

  • 1. Treatment of high-risk chronic GVHD.
    Pavletic S, Vogelsand GB.
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1436-7. PubMed ID: 19041069
    [No Abstract] [Full Text] [Related]

  • 2. Allogeneic stem cell transplantation after reduced-intensity conditioning for acute myeloid leukaemia: impact of chronic graft-versus-host disease.
    Valcárcel D, Martino R, Piñana JL, Sierra J.
    Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S35-7. PubMed ID: 19561412
    [Abstract] [Full Text] [Related]

  • 3. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
    Guo M, Sun Z, Sun QY, Han Q, Yu CL, Wang DH, Qiao JH, Chen B, Sun WJ, Hu KX, Liu GX, Liu B, Zhao RC, Ai H.
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
    [Abstract] [Full Text] [Related]

  • 4. [Usefulness of a slow-release tacrolimus for a patient with tacrolimus-induced renal injury after hemopoietic stem cell transplantation].
    Hosonuma R, Fujiwara S, Sasazaki M, Hirata Y, Yamamoto C, Uesawa M, Oh I, Matsuyama T, Mori M, Ozawa K, Muroi K.
    Rinsho Ketsueki; 2012 Apr; 53(4):469-71. PubMed ID: 22687983
    [Abstract] [Full Text] [Related]

  • 5. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, Chen YH, Zhang XH, Lu DP.
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [Abstract] [Full Text] [Related]

  • 6. Target blood concentrations of CYA and tacrolimus in randomized controlled trials for the prevention of acute GVHD after hematopoietic SCT.
    Oshima K, Sato M, Terasako K, Kimura S, Okuda S, Kako S, Kanda Y.
    Bone Marrow Transplant; 2010 Apr; 45(4):781-2. PubMed ID: 19701249
    [No Abstract] [Full Text] [Related]

  • 7. Gastrointestinal chronic graft-versus-host disease: management options.
    Awan F, Hamadani M.
    J Oncol Pharm Pract; 2007 Mar; 13(1):49-51. PubMed ID: 17621568
    [Abstract] [Full Text] [Related]

  • 8. Cross-sensitivity reaction between tacrolimus and macrolide antibiotics.
    Riley L, Mudd L, Baize T, Herzig R.
    Bone Marrow Transplant; 2000 Apr; 25(8):907-8. PubMed ID: 10808214
    [Abstract] [Full Text] [Related]

  • 9. Very late appearance of acute graft-versus-host disease after tapering immunosuppression.
    Wollina U, Sayer HG, Wollina K, Graefe T.
    J Dermatol; 2001 Dec; 28(12):734-6. PubMed ID: 11804070
    [Abstract] [Full Text] [Related]

  • 10. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ, Min WS, Cho BS, Eom KS, Kim YJ, Min CK, Lee S, Cho SG, Jin JY, Lee JW, Kim CC.
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dramatic increase of tacrolimus plasma concentration during topical treatment for oral graft-versus-host disease.
    Conrotto D, Carrozzo M, Ubertalli AV, Gandolfo S, Giaccone L, Boccadoro M, Bruno B.
    Transplantation; 2006 Oct 27; 82(8):1113-5. PubMed ID: 17060865
    [No Abstract] [Full Text] [Related]

  • 14. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF, Fan ZP, Zhang Y, Jiang ZJ, Wang CY, Xu D, Sun J, Xiao Y, Tan H.
    Biol Blood Marrow Transplant; 2009 Nov 27; 15(11):1376-85. PubMed ID: 19822296
    [Abstract] [Full Text] [Related]

  • 15. Human adipose tissue-derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs.-host disease in two children.
    Fang B, Song Y, Lin Q, Zhang Y, Cao Y, Zhao RC, Ma Y.
    Pediatr Transplant; 2007 Nov 27; 11(7):814-7. PubMed ID: 17910665
    [Abstract] [Full Text] [Related]

  • 16. Alloimmune hepatitis following peripheral stem cell transplantation.
    Habib S, Nalesnik MA, Ahmad J, BuchBarker D, Shakil AO.
    Bone Marrow Transplant; 2007 May 27; 39(9):573-5. PubMed ID: 17369864
    [No Abstract] [Full Text] [Related]

  • 17. Life-threatening acute pancreatitis due to thalidomide therapy for chronic graft-versus-host disease.
    Chung LW, Yeh SP, Hsieh CY, Liao YM, Huang HH, Lin CY, Chiu CF.
    Ann Hematol; 2008 May 27; 87(5):421-3. PubMed ID: 18040684
    [No Abstract] [Full Text] [Related]

  • 18. [Retrospective analysis of posterior reversible encephalopathy syndrome after allogeneic stem cell transplantation].
    Aisa Y, Mori T, Shimizu T, Tsukada Y, Kato J, Suzuki S, Suzuki N, Ikeda Y, Okamoto S.
    Rinsho Ketsueki; 2009 Jan 27; 50(1):9-15. PubMed ID: 19225223
    [Abstract] [Full Text] [Related]

  • 19. Acute graft-versus-host disease (GVHD) overlapping chronic GVHD after reinduction chemotherapy.
    Delgado-Jimenez Y, Goiriz R, Vargas-Diez E, Fraga J, Garcia-Diez A, Fernandez-Herrera J.
    Br J Dermatol; 2007 Feb 27; 156(2):388-90. PubMed ID: 17223891
    [No Abstract] [Full Text] [Related]

  • 20. Human parvovirus B19 infection with GvHD-like erythema in two allogeneic stem cell transplant recipients.
    Muetherig A, Christopeit M, Müller LP, Grothe W, Weber T, Theurich S, Behre G.
    Bone Marrow Transplant; 2007 Mar 27; 39(5):315-6. PubMed ID: 17311086
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.